Site US403 — Seattle, Washington

Site US403 is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US403 has participated in 1 clinical trials.

Therapeutic areas: Solid Tumors.

Sponsors: Astellas Pharma Inc.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US403?

Site US403 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US403 conducted?

Site US403 has 1 clinical trials on record. Their work covers Solid Tumors.

Is Site US403 accredited by Crixeo Health?

Site US403 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US403?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.